Characteristics of cytochrome P-450 and mixed function oxidase enzymes following treatment with PBBs. by Dent, J G
Environmental Health Perspectives
Vol. 23, pp. 301-307, 1978
Characteristics of Cytochrome P-450 and
Mixed Function Oxidase Enzymes
Following Treatment with PBBs
by J. G. Dent*
The mixture ofPBBs in FireMaster BP-6 has been demonstrated toconstitute potent inducers ofhepatic
and extrahepatic mixed function oxidase (MFO) enzymes. Chronic dietary administration of PBBs to
mature female rats results in a "mixed" pattern of induction, with increases in both cytochrome P-450
and P,-450 associated enzymes. Acute administration of PBBs (150 mg/kg IP) to mature female rats
resulted in a time-dependent induction of MFO activities; the P450-dependent enzymes were simulated
early (24-48 hr after administration) while the P,-450 dependent enzymes reached maximal activities at
later time points. However, studies ofthe kinetics and patterns ofinhibition ofthe induced enzymes along
with gel electrophoresis studies of the microsomal proteins indicate that PBBs may induce different
proteins from those induced by the classical P-450 and P,-450 inducers, phenobarbital and 3-
methylcholanthrene. In addition, the pattern of enzyme induction caused by PBBs in developing rats
differs from that in adults, in that the P,450-associated enzymes are stimulated prior to the P450-
associated enzymes. The overall pattern ofenzyme induction in extrahepatic tissue differs from that seen
in the liver and sex differences in enzyme induction have also been demonstrated. As modifications of
MFO activity may alter the toxicity ofchemicals, these findings suggest that the toxicity ofchemicals may
be altered in animals exposed to PBBs and that these toxicities may exhibit age, sex, and organspecificities
different from those seen in control animals.
Introduction
The polybrominated biphenyls (PBBs) have,
since 1974, become recognized as environmental
contaminants, particularly in Michigan (1, 2) and
more recently in other states in America (3). The
PBBs in FireMaster BP-6 (also referred to as Fire-
Master FF-I when mixed with an anticaking agent,
calcium polysilicate) are a mixture of brominated
biphenyls, of which the major components are 2,-
2',4,4',5,5'-hexabromobiphenyl, which comprises
about 60% of the mixture (4-6), and 2,2',4,-
4',5,5'-heptabromobiphenyl, which has been
reported to constitute 27% (7) or 11% (8) by weight.
In addition, otherbromobiphenyls are present in the
mixture (8), along with traces of hexa- and penta-
brominated naphthalenes and a methyl polybrom-
inated furan (2).
Early studies of the toxicity of octabromobi-
phenyl indicated low acute toxicity but concluded
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that this compound was biologically persistent (9,
10). Similarly, FireMaster BP-6 appeared to have
low acute toxicity and a long biological half-life (8,
11). Because of the chemical similarities between
polychlorinated biphenyls (PCBs) and PBBs, it was
predicted that the PBBs would have similar biologi-
cal properties to the PCBs. One of the most potent
and thoroughly investigated properties of PCBs is
their effects on mixed function oxidase activity
(12-15).
The mixed function oxidase system (MFO) is lo-
cated in the endoplasmic reticulum of many mam-
malian cells (16-18). This enzyme system, which
has as its terminal oxidase cytochrome P-450, is re-
sponsible for the metabolism of many xenobiotics
and endogenous compounds (/9). Many
chemicals-drugs, pesticides, herbicides and en-
vironmental contaminants-cause alterations in the
activity of the MFO system by induction of cyto-
chrome P-450 and the enzyme activities associated
with it (17). There are several types of cytochrome
P-450 inducing agents, but in the main they fall into
two distinct classes (20, 21). The first class,
April 1978 301exemplified by phenobarbital (PB), induces cyto-
chrome P-450 and a wide range of enzyme ac-
tivities. The second class is exemplified by 3-
methylcholanthrene (3MC) which induces a more
specific range ofenzyme activities and cytochrome
P1-450 (P-448), a cytochrome which differs in sev-
eral ofits physical and chemical properties from the
cytochrome P-450 found in control or PB-treated
animals (20, 21).
It was first reported in 1973 that a commercial
mixture ofPCBs, Aroclor 1254, shared the inducing
properties ofboth PB and 3MC (12). Aroclor 1254 is
a mixture of PCBs containing 54% by weight
chlorine. The major portion of this mixture is
hexachlorobiphenyl. Because of the similarities
between PCBs and PBBs, it was predicted that
FireMaster BP-6 might similarly be a "'mixed" in-
ducer of the MFO system.
To date, the effects of the mixture of PBBs in
FireMaster BP-6 on hepatic and extrahepatic MFO
activity in neonatal and adult rodents have been in-
vestigated. In addition, several studies ofthe effects
ofpurified components ofthe FireMaster BP-6 have
been reported. This paper reviews these data and
discusses the toxicological consequences of these
findings.
Effects of PBBs on Hepatic Mixed
Function Oxidase
Preliminary studies on FireMaster BP-6 sup-
ported the contention that this mixture caused
stimulation of hepatic MFO systems (22). The pat-
tern ofenzyme induction resulting from exposure to
PBBs was characterized in a two-week feeding
study. Female rats werefed adiet containing4.96 to
300 ppm FireMaster BP-6, and the profile ofhepatic
MFO activity which resulted was compared with
that observed after a maximal inducing dose of PB
or 3MC (23). The results from this study clearly
indicated that the properties of the PBB mixture
were characteristic of a "mixed" inducer. After 2
weeks exposure to 75 and 300 ppm, ethylmor-
phine-N-demethylase activity was elevated to ap-
proximately the same extent as seenafter amaximal
inducing dose of PB; 3MC treatment did not in-
crease this enzyme activity. 3-Methylcholanthrene
caused an elevation of ethoxycoumarin-O-deeth-
ylase and aryl hydrocarbon hydroxylase (AHH) to
40 and 35 times control activity, respectively.
Phenobarbital had a much smaller effect on both
these enzymes, causing a 9- and 5-fold increase,
respectively. At 75 and 300 ppm, PBBs had an ef-
fect intermediate between that of PB and 3MC on
these enzymes (23). In keeping with these observa-
tions, a blue shift in the Xmax ofthe difference spec-
trum ofthe reduced cytochrome P450-CO complex
was observed in microsomes from PBB-treated
animals. The Soret region absorption maxima for
the reduced cytochrome P-450-CO complex in
control and PB-treated rats is normally close to 450
nm. Treatment of animals with 3MC results in a
blue shift ofthis maximum by about 2 nm to 448 nm
(24).
From data obtained in the study described above
(23), it was estimated that the dose of PBBs re-
quired to produce maximal induction was between
75 and 300 mg/kg in female rats. In a second study
(25) a single injection of PBBs was administered
intraperitoneally to female rats at 25 or 150 mg/kg,
and the time course and pattern of induction
studied. Both doses ofPBBs resulted in increases in
hepatic MFO enzymes sensitive to either PB or
3MC. However, the time at which these enzyme
activities reached maximal values differed. The
P450 associated enzymes, those normally sensitive
to phenobarbital, were maximally increased at 48 hr
after 150 mg/kg. The P,-450-associated enzymes
(3MC-sensitive) reached maximal activities at later
times. Similar results were also observed in mice
treated with a single dose ofPBBs at 150 mg/kg (26).
The PB-sensitive enzymes were maximally stimu-
lated 48 hr after treatment, and the 3MC-sensitive
enzymes 96 hr after treatment with PBBs. In both
rats and mice, these changes in enzyme activity
were not correlated with changes in cytochrome
P-450 content. In both species, the microsomal cy-
tochrome P-450 content increased to maximal levels
by 24-48 hr after treatment and then remained ele-
vated and essentially constant for up to 336 hr.
However, time-dependent changes in the character
ofthe cytochrome P-450 and some ofthe associated
enzymes were detected.
Several methods have been employed to charac-
terize the type ofcytochrome P-450 induced by dif-
ferent compounds. The Xmax of the reduced cyto-
chrome P450-CO complex is altered by P1450 in-
ducing agents (24). The ratio ofthe peaks at455 and
430 nm in the ethyl isocyanide difference spectra is
increased by P1450 inducing agents, whereas P-450
inducing agents have little or no effect on this ratio
(27). Enzyme inhibitors have also been used to
selectively inhibit P-450 and P1-450-dependent en-
zyme activity. Typically, metyrapone preferentially
inhibits P-450 mediated AHH activity and a-
naphthoflavone inhibits P1-450-mediated AHH (28,
29). In addition, the pattern of protein staining
bands between 40,000-60,000 daltons on sodium
dodecylsulfate gel electrophoretograms are
characteristic of the types of cytochrome(s) P450
present in microsomes (15).
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to rats, the maximal shift in the Xmax forthe reduced
cytochrome P450-CO complex was observed 192
hr after treatment, when the complex absorbed at
448.5 nm compared to 449.1 nm in controls and
448.0 nm in animals treated with a combination of
PB and 3MC (25). Following five daily injections of
PBBs at 90 mg/kg in male rats, the Xmax of the re-
duced P450-CO complex was observed at 449.5
nm, compared to 448 and 450 nm in microsomes
from 3MC- and PB-treated animals, respectively
(7). In both rats (25) and mice (26), PBBs cause a
change in the ratio of the peaks in the ethyl
isocyanide difference spectrum to a value inter-
mediate between those observed in microsomes
from PB- and 3MC-treated animals. In addition,
time-dependent changes in the peak ratios reflected
the time-dependent changes observed in the en-
zyme activities (30).
Changes were also observed in the sensitivity of
AHH and ethoxycoumarin-O-deethylase activity to
the inhibitors metyrapone and a-naphthoflavone
(30). Following treatment with PBBs, AHH activity
became less sensitive to metyrapone while the
deethylase activity became more sensitive to
metyrapone. Both enzymes were inhibited by a-
naphthoflavone to the same extent as seen in con-
trol or 3MC-treated animals. No time-dependent
change in the sensitivity to a-naphthoflavone could
be detected (30).
The inhibitor and spectral studies in conjunction
with the pattern of enzyme activity induced by
PBBs support the contention that the mixture of
PBBs in FireMaster BP-6 cause "mixed" induction
of cytochrome P-450-dependent enzymes. Fur-
thermore, the pattern of induction observed
changes with time after a single injection of PBBs.
The changes can be summarized as PB-like (cyto-
chrome P-450) stimulation at early times after
treatment followed by a 3MC-like (Pl-450 stimula-
tion) at later times. However, electrophoretic
studies of microsomes from PBB-treated rats pro-
duced results which are in conflict with this de-
scription of the pattern of induction. When micro-
somes from control and PB-treated animals were
submitted to electrophoresis on SDS polyac-
rylamide gels, the pattern ofprotein staining bands
in the 40,000-60,000 dalton range are very similar.
Microsomes from 3MC-treated animals show a dis-
tinct band in the region 58,000 daltons which is not
evident in microsomes for control of PB-treated
animals (30), although the purified P,-450 heme-
protein induced by 3MC is reported to have a
molecular weight of about 53,000 daltons (15). The
studies of the inducing properties of the PBBs de-
scribed above clearly indicate that they have a
3MC-like component associated with the pattern of
enzyme induction they produce. It is therefore sur-
prising that no protein staining band corresponding
to the band at 58,000 daltons could be found in mi-
crosomes from PBB-treated animals. This observa-
tion in conjunction with inhibitor, spectral, and
kinetic data led to the suggestion that PBBs may be
a different class of inducing agent from the PCBs
and led to the speculation that PBBs may not
merely act by initiating de novo protein synthesis,
but may also affect the association ofthe subunits of
cytochrome(s) P-450 in the microsomal membrane
(30).
However, recent results from Moore et al. (6, 31)
indicate that in male rats PBBs produce a polypep-
tide pattern on SDS gel electrophoresis which,
judged by both protein and heme staining tech-
niques, resemble the pattern of polypeptides seen
after combined PB and 3MC treatment. The reason
for these interlaboratory differences is unclear.
They may relate to sex or strain differences or they
may be a function of the interpretation of the elec-
trophoretic gels. Gel electrophoretograms of whole
microsomes are difficult to interpret, especially
when using protein stains, due to the large amount
of non-cytochrome P-450 related protein, and the
presence of other proteins in the 40,000-60,000
dalton range (32, 33). Unambiguous identification of
the cytochrome P-450 related hemeproteins induced
by PBBs awaits purification ofthe cytochromes in-
volved. Interestingly, in a recent study of purified
cytochrome P-450 from rats treated with Aroclor
1254, Ryan et al. (15) concluded from spectral, elec-
trophoretic, immunological, and kinetic data that
the PCBs did induce cytochrome P450 hemepro-
teins which were, in almost every respect, identical
to a mixture ofPB and 3MC-induced hemeproteins.
A similar experimental approach will unambigu-
ously establish the nature of the hemeproteins in-
duced by PBBs.
Inducing Properties of the Com-
ponents of FireMaster BP-6
The time-dependent changes in MFO activity
following administration of PBBs discussed above
could be due to differences in the susceptibility of
the different enzymes to induction. Alternatively,
these time-dependent changes could relate to the
pharmacokinetics of the constituents of the PBB
mixture. Studies of the rate of absorption of the
PBB cogeners from the peritoneal cavity of young
rats indicate that there are no detectable differences
in the rates of absorption of the major components
of the mixture during the first 14 days after an in-
traperitoneal injection (34). This observation does
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of the PBB mixture is more slowly absorbed, and
that this component is responsible for the 3MC-like
induction. As yet we do not know in detail which
components of the mixture are responsible for
which of the biochemical effects.
The first ofthe components ofthe PBB mixture to
be isolated, purified, and investigated biochemically
is the major component 2,2',4,4',5,5'-hexabromo-
biphenyl (6). This isomer, which has been purified
to better than 99o, clearly has the properties of a
PB-type inducing agent. The hexabromobiphenyl
isomer increases cytochrome P-450 concentration
without changing the X,n. for the P-450-CO com-
plex and causes increases in enzyme activity which
are almost identical to those resulting from PB
treatment (6, 31). Moore et al. have also isolated the
second most abundant component in FireMaster
BP-6, namely 2,2',3,4,4',5,5'-heptabromobiphenyl
(7), and a minor component 2,2'-dibromobiphenyl
(31). Studies ofthe inducing properties ofthese two
isomers led to the conclusion that the heptabromo
isomer has PB-like inducing properties while the di-
bromo isomer does not have a significant effect on
MFO activity (31). Although Moore et al. (6, 31)
have, as yet, only studied the inducing properties of
three pure PBB cogeners, the pattern of induction
produced by these pure compounds is similar to
those of the corresponding purified PCBs. In an
extensive study of the inducing properties of
purified PCBs, Goldstein et al. (14) concluded that
the absence ofchlorine atoms in the ortho positions
of the biphenyl rings was a prerequisite for the
isomer to exhibit a 3MC-like inducing effect. They
postulate that coplanarity of the biphenyl rings is a
prerequisite for a P1450 induction; coplanarity is
inconsistent with ortho-substituted chlorines. They
found that 2,2'-dichlorobiphenyl was inactive as an
inducer; Moore et al. (31) found similar results for
the corresponding 2,2'-dibromobiphenyl.
Stimulation of Extrahepatic
Mixed Function Oxidase Activity
by PBBs
While the liver is recognized as the majororgan of
xenobiotic metabolism, studies of MFO activity in
extrahepatic tissue reveal a diversity oforgans with
the ability to metabolize xenobiotics (16-18). In ad-
dition, there is an increased awareness of the po-
tential role ofthe MFO systems in specific organs in
the response of the organs to the toxic action of a
chemical. Therefore, the effects of PBBs on extra-
hepatic MFO activity is of considerable interest.
In the light ofreports ofdetectable levels ofPBBs
in human breast milk (ll) and the observation that
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milk forms a major route of excretion of PBBs in
cattle (35), the effects of PBBs on mixed function
oxidase activity in mammary tissue warrant atten-
tion. When pregnant rats were fed 50 ppm PBB
from day 8 ofgestation until day 14 postpartum, the
mammary glands had approximately 30 times higher
concentrations of PBBs than the liver. The mam-
mary AHH activity was three times higher in
treated animals than in the controls. This elevated
AHH activity, although not as great as that ob-
served in the liver, where a 10-fold increase was
noted, was accompanied by a decrease in epoxide
hydratase activity to half the control activity (36).
The decrease in epoxide hydratase activity after
treatment with PBBs, while unusual, is not confined
to mammary tissue. In another series of experi-
ments, male rats were fed 100 ppm PBBs for 3
months. When the renal AHH and epoxide hydra-
tase activities were measured, AHH was elevated
to ten times control levels, whereas the epoxide hy-
dratase activity was barely detectable in the PBB-
treated animals and represented approximately 10%
of control activity (37). These effects were not re-
produced by a single injection of PBBs in develop-
ing rats (38). In these studies, 7-day-old rats re-
ceived a single IP injection of 150 mg/kg PBBs.
Renal ethoxyresorufin-O-deethylase and AHH ac-
tivity was increased above control activity by 7
days after treatment and remained elevated 63 days
after treatment. In contrast, renal hexobarbital and
biphenyl hydroxylase activities could not be de-
tected in control animals, and were not detectable in
PBB-treated animals. Renal epoxide hydratase was
unchanged by PBB treatment (38). McCormack et
al. also report the PBBs alone or in combination
with PCBs cause dose-related increases in renal,
mammary, hepatic, and pulmonary AHH activity
(40). They conclude that FireMaster BP-6 is more
potent, on a weight basis, as an enzyme inducer
than Aroclor 1254, in agreement with the results of
Garthoff et al. (22), and that no synergism was
noted between PBBs and PCBs in their inducing
properties, although some additive effects of these
two mixtures on MFO activity was noted. In con-
trast, Elcombe and Lech report that PBBs are less
potent inducers of hepatic MFO activity in trout
than are the PCBs Aroclor 1242 and 1254 (39). Their
results also suggest that PBBs have different in-
ducing properties from the PCBs.
Effects of PBBs on MFO Activity in
Neonatal Animals
It was first reported in early 1976 by Moore et al.
that PBBs, when fed to nursing rats at doses as low
as 1 ppm in the diet for 18 days postpartum, caused
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suckling pups, but had little effect on hepatic MFO
activity in the mother atthis dose (41). These results
are presumably a reflection ofthe bioconcentration
of PBBs in breast milk which leads to the suckling
pups receiving a high dose of PBB relative to their
body weights. The PBBs do not only cause enzyme
induction when transferred to the suckling pup in
the breast milk. Circumstantial evidence also exists
that transplacental passage of PBBs occurs, al-
though this is not surprising in light of the known
ability of the PCBs to cross the placental barrier
(42). In an experiment designed to distinquish the
pre- and postnatal effects of PBBs, pregnant rats
were fed diet containing 50 ppm PBBs from day 8 of
gestation until day 14 postpartum. At birth, all pups
were cross fostered so that they received 0 ppm
PBBs or were exposed to PBBs either prenatally,
postnatally or both pre- and postnatally. In all pups
exposed to PBBs, regardless of the exposure regi-
men, elevated hepatic AHH and EH activity was
detected. Combined pre- and postnatal exposure
caused the greatest increases (43). It was concluded
that PBBs were effective prenatal inducing agents
and their effects were assumed to result from trans-
placental passage of PBBs. This assumption was
supported by analytical findings ofPBBs in animals
born to mothers fed PBBs, but fostered by control
animals (44).
When the enzyme inducing properties of PBBs
were investigated in developing rats by injecting
7-day-old animals with 150 mg/kg (37), several in-
teresting phenomena were observed. Firstly, in the
liver, 3MC-sensitive P1-450-dependent enzymes
were elevated earlier than the PB-sensitive P-450
dependent enzymes. This presumably reflects the
greater sensitivity of the developing rat to 3MC-
type inducing agents (45). In addition, when MFO
activities in the males were compared with those in
the females, 28 and 63 days after treatment (the
animals were then 35 and 70 days old) a greater
incidence of sex differences in enzyme activities
was observed as compared to control animals.
Furthermore, renal ethoxyresorufin-O-deethylase
and AHH activities were higher in treated females
than in treated males, a reversal of the normal pat-
tern of sex-dependent differences in enzyme activ-
ity.
Toxicological Consequences
of Mixed Function Oxidase
Stimulation by PBBs
In general, the PBBs have a relatively low acute
toxicity in mammals. The acute LD50 in rats for
FireMaster BP-6 is reported to be 21.5 g/kg (8). In
addition, several studies have reported prolonged
exposure oflaboratory rodents to PBBs at doses up
to 1000 ppm in the diet, without excessive or overt
toxic effects (2). However, there are indications
that the PBBs may be carcinogenic (46) and
teratogenic (2) in rodents at high doses. Consider-
able effort is now being directed towards identifying
the human health hazards associated with exposure
to PBBs.
How do the studies reviewed here relate to the
potential human health hazard associated with ex-
posure to PBBs, and how may they be used to assist
in further investigations in this area?
Enzyme inducing agents have been shown to
modify the toxicity of chemicals (44-49). Both PB
and 3MC modify the toxicity ofagents such as CCl4,
acetaminophen, and bromobenzene. The PCB
Aroclor 1254 has been shown to increase the tox-
icity ofCC14 (50). These changes in toxicity relate to
changes in the pattern or rate of metabolism of the
toxic agents. Different classes of inducing agents
have different effects on the toxicity of secondary
compounds. For example, pretreatment of animals
with PB enhances the hepatotoxicity of bromoben-
zene while 3MC-pretreated animals are protected
from the hepatotoxicity of this agent (51). As the
inducing properties ofPBBs change with time, after
a single dose, from PB-like at early times to 3MC-
like at later times after administration (25, 26) it was
predicted that PBBs would modify the toxicity of
bromobenzene in a time dependent fashion. This
proved to be the case. At early times after PBB
administration, the toxicity of bromobenzene was
modified in a PB-like manner; at later times after
administration, PBBs had a 3MC-like effect on
bromobenzene toxicity (52).
The observed age, sex, and organ specific re-
sponses of the MFO system to PBBs suggest that
the toxicity of secondary agents in PBB exposed
animals may be age, sex and organ dependent. The
depression of epoxide hydratase in kidney and
mammary tissue implies that the ability ofthese or-
gans to convert epoxides to dihydrodiols may be
compromised. In light of the postulated role of
epoxides in the toxicity of alkene and arene com-
pounds (53) the consequences ofthese biochemical
changes elicited by PBB exposure may be far
reaching. The hepatotoxicity and nephrotoxicity of
chloroform is enhanced by prior exposure of mice
to PBBs (54). In addition, changes in the MFO sys-
tem in the mammary gland could have nutritional
and toxicological consequences for the suckling
young. In recent years, the role of milk in the
transfer of foreign compounds from mother to
young has been recognized (54). We may speculate
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may alter both the quantity and chemical identity of
compounds transferred from mother to young in the
milk.
The observed accumulation of PBB in the testes
and ovaries of rats exposed to PBB (34) may be a
reflection of the high fat content of these organs.
However, the biological consequences of this ac-
cumulation have not been investigated. Whether
PBBs modify MFO activity inthe sex organs remains
to be determined. Changes in sexual function have
been reported in animals exposed to PCBs (56).
Whether similar changes occur in PBB exposed ani-
mals has not been determined. Conceivably modifi-
cation of MFO activity in sex organs could alter the
metabolism of sex hormones in these organs as well
as any effect that may occur in the liver. The PCBs
have been shown to modify metabolism ofthyroxine
in rats (57). Mixed function oxidase inducers are
known to modify the metabolism of many endogen-
ous and exogenous compounds in man including the
sex hormones (58).
In conclusion, a recent report (45) estimated that
human exposure to PBBs may in some cases be as
much as 200 mg/kg. While this estimate may be
high, the animal studies reviewed here indicate that
low doses of PBBs in rodents have a significant ef-
fect on MFO activity. These observations, com-
bined with the long biological half-life of the PBBs
and their propensity to accumulate in the body,
raise concern as to the effects of PBBs on MFO
activity in the exposed human population. Clearly,
the potential health effects of altered MFO activity
warrants consideration in future studies of the
human population exposed to polybrominated
biphenyls.
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